[Very late intrastent thrombosis--at 27 months!]

Arch Mal Coeur Vaiss. 2007 Mar;100(3):217-20.
[Article in French]

Abstract

Interrupting platelet antiaggregant therapy in coronary patients treated by stenting exposes them to the risk of cardiac complications. The risk of acute thrombosis of the stent is well known but late intrastent thrombosis is less common and mainly observed with drug eluting stents. The authors report the case of a 54 year old man who had thrombosis of an ordinary stent implanted 27 months previously which occurred in the immediate post-operative period after repair of an inguinal hernia. The interruption of platelet antiaggregant therapy was relayed by flurbiprofen in accordance with recommendations of scientific societies. After a review of the literature, the authors discuss late stent thrombosis and interruption of platelet aggregant therapy in coronary patients before non-cardiac surgery.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aspirin / administration & dosage
  • Aspirin / therapeutic use
  • Clopidogrel
  • Coronary Thrombosis / etiology*
  • Fatal Outcome
  • Flurbiprofen / administration & dosage
  • Flurbiprofen / therapeutic use
  • Follow-Up Studies
  • Hernia, Inguinal / surgery*
  • Humans
  • Laparoscopy
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / therapeutic use
  • Postoperative Complications*
  • Stents*
  • Ticlopidine / administration & dosage
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Flurbiprofen
  • Clopidogrel
  • Ticlopidine
  • Aspirin